Your browser doesn't support javascript.
loading
Randomized, placebo-controlled, phase III trial of sunitinib plus prednisone versus prednisone alone in progressive, metastatic, castration-resistant prostate cancer.
Michaelson, M Dror; Oudard, Stephane; Ou, Yen-Chuan; Sengeløv, Lisa; Saad, Fred; Houede, Nadine; Ostler, Peter; Stenzl, Arnulf; Daugaard, Gedske; Jones, Robert; Laestadius, Fredrik; Ullèn, Anders; Bahl, Amit; Castellano, Daniel; Gschwend, Juergen; Maurina, Tristan; Chow Maneval, Edna; Wang, Shaw-Ling; Lechuga, Maria Jose; Paolini, Jolanda; Chen, Isan.
Afiliación
  • Michaelson MD; M. Dror Michaelson, Massachusetts General Hospital Cancer Center, Boston, MA; Stephane Oudard, George Pompidou European Hospital, Rene Descartes University, Paris; Nadine Houede, Institut Bergonie, Bordeaux; Tristan Maurina, CHU de Besançon, Hôpital Jean Minjoz, Besançon, France; Yen-Chuan Ou, Taichung Veterans General Hospital, Taichung, Taiwan; Lisa Sengeløv, Herlev Hospital, Herlev; Gedske Daugaard, Rigshospitalet, Copenhagen, Denmark; Fred Saad, University of Montreal, Montreal, Canada; Pete
J Clin Oncol ; 32(2): 76-82, 2014 Jan 10.
Article en En | MEDLINE | ID: mdl-24323035

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Prednisona / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2014 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Prednisona / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Año: 2014 Tipo del documento: Article